Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and thank you ...

Tandem Diabetes Care (NASDAQ:TNDM) reported record fourth-quarter and full-year 2025 results while outlining a major shift in ...

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the Blood Glucose Monitoring Devices Market is projected to grow from USD 16,202.5 ...

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from ...

McCune Law Group has filed a wrongful death lawsuit against Abbott Diabetes Care Inc. and Abbott Laboratories over alleged defects in the FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United ...

Abbott Laboratories (NYSE:ABT) is one of the best 52-week low blue-chip stocks to buy right now. Reuters reported on February ...

American freestyle skiers are facing intense backlash on social media after comments made about representing the United States at the 2026 Milan Cortina Winter Olympics amid the Trump administration’s ...

The 2026 Winter Olympics is officially underway, and freestyle skiing is one of the awaited competitions. The events, which challenge athletes' speed, acrobatics and technique, will be held in Livigno ...

Abbott recalls glucose sensors linked to 7 deaths and 860 serious injuries; FDA urges discontinuation of specific FreeStyle Libre 3 models.

Around 1 million drivers have been given a key health condition update from the Department for Transport. Officials responded to a Parliamentary written question asking about the monitoring process ...